BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1712558)

  • 1. Inhibition of interleukin-3-dependent growth of CD34+ acute myelogenous leukemia cells by recombinant soluble CD23.
    Mossalayi MD; Merle-Beral H; Dalloul AH; Arock M; Michel A; Hofstetter H; Debre P
    Ann N Y Acad Sci; 1991; 628():362-7. PubMed ID: 1712558
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of CD23 on purified human hematopoietic cells.
    Mossalayi D; Dalloul A; Arock M; Debre P
    Bone Marrow Transplant; 1992; 9 Suppl 1():50-3. PubMed ID: 1387018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of interleukin 1 and soluble CD23 on the growth of human CD4+ bone marrow-derived T cells.
    Bertho JM; Fourcade C; Dalloul AH; Debré P; Mossalayi MD
    Eur J Immunol; 1991 Apr; 21(4):1073-6. PubMed ID: 1673432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23.
    Mossalayi MD; Arock M; Bertho JM; Blanc C; Dalloul AH; Hofstetter H; Sarfati M; Delespesse G; Debré P
    Blood; 1990 May; 75(10):1924-7. PubMed ID: 2140059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation.
    Mossalayi MD; Lecron JC; Dalloul AH; Sarfati M; Bertho JM; Hofstetter H; Delespesse G; Debre P
    J Exp Med; 1990 Mar; 171(3):959-64. PubMed ID: 2137858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic epithelial cell-derived supernatants sustain the maturation of human prothymocytes: involvement of interleukin 1 and CD23.
    Dalloul AH; Fourcade C; Debré P; Mossalayi MD
    Eur J Immunol; 1991 Oct; 21(10):2633-6. PubMed ID: 1717288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diverged homeobox gene is involved in the proliferation and lineage commitment of human hematopoietic progenitors and highly expressed in acute myelogenous leukemia.
    Deguchi Y; Kirschenbaum A; Kehrl JH
    Blood; 1992 Jun; 79(11):2841-8. PubMed ID: 1375114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fc gamma receptor expression and antibody-dependent cellular cytotoxicity of hematopoietic progenitor cells during in vitro myeloid maturation.
    Ericson SG; Benoit NE; Mills LE; Fanger MW
    Exp Hematol; 1994 Mar; 22(3):283-9. PubMed ID: 7509291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD23 increases IL-3 induction of histamine synthesis by human bone marrow cells.
    Arock M; Michel L; Dalloul AH; Guillosson JJ; Debré P; Mossalayi MD
    Int Arch Allergy Appl Immunol; 1991; 96(2):190-2. PubMed ID: 1837540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE-binding factors (soluble CD23) and IgE regulation.
    Delespesse G; Sarfati M
    Res Immunol; 1990 Jan; 141(1):75-7; discussion 105-8. PubMed ID: 2140615
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis.
    Liu YJ; Cairns JA; Holder MJ; Abbot SD; Jansen KU; Bonnefoy JY; Gordon J; MacLennan IC
    Eur J Immunol; 1991 May; 21(5):1107-14. PubMed ID: 1828027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-affinity receptor for IgE (FcERII, CD23) and its soluble fragments.
    Delespesse G; Hofstetter H; Sarfati M
    Int Arch Allergy Appl Immunol; 1989; 90 Suppl 1():41-4. PubMed ID: 2533179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway.
    Taieb J; Leca G; Auffredou MT; Galanaud P; Vazquez A
    Eur Cytokine Netw; 1991; 2(4):265-72. PubMed ID: 1721849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential responses of CD34-positive acute myelogenous leukemic blasts to the costimulating effects of stem cell factor with GM-CSF and/or IL-3.
    Min YH; Lee ST; Lee BK; Chong SY; Lee S; Hahn JS; Ko YW
    Yonsei Med J; 1995 Mar; 36(1):26-36. PubMed ID: 7537932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive proliferative capacity of single isolated CD34 human cord blood cells in suspension culture.
    Xiao M; Broxmeyer HE; Horie M; Grigsby S; Lu L
    Blood Cells; 1994; 20(2-3):455-66; discussion 466-7. PubMed ID: 7538351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Soluble CD23: cytokine actives on human hematopoietic precursors].
    Mossalayi MD; Dalloul AH; Debré P
    C R Seances Soc Biol Fil; 1991; 185(4):198-205. PubMed ID: 1836414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40.
    Banchereau J; de Paoli P; Vallé A; Garcia E; Rousset F
    Science; 1991 Jan; 251(4989):70-2. PubMed ID: 1702555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.